Lilly will also gain certain rights to MeiraGTx’s proprietary riboswitch technology for use in gene editing in the eye. Under ...

Eli Lilly will partner with Insilico Medicine on an artificial intelligence (AI)-based drug development collaboration that they said could generate “over $100 million” for the AI drug discovery ...

The companies will use clinical trial plasma samples and data to drive the AthosOmics.AI platform to identify efficacy biomarkers for Xeptiva's lead experimental therapeutic vaccine for canine ...

Eli Lilly is inking a $100 million-plus biobucks deal with Insilico Medicine in hopes of using AI to discover new drugs. | Eli Lilly is inking a $100 million-plus biobucks deal with Insilico Medicine ...

Insilico Medicine announced a research collaboration with Eli Lilly (LLY) that the two parties will combine Insilico’s Pharma.AI platforms with ...

Datavault AI Inc. (NASDAQ: DVLT), a leader in data monetization, credentialing, and digital engagement technologies, today released an Investor Update ...

Current scope of work: Asa Abeliovich, M.D., is founder and chief executive officer of Leal Therapeutics, a biotech company ...

The greater part of third quarter earnings results is behind us, though notable reports from CoreWeave , The Walt Disney ...

Harmonic today announced that Walter Jankovic, CFO of Harmonic, will host investor meetings at the 6th Annual Needham Tech Week Conference in New York, NY, on Thursday, November 20, ...

Pipeline programs continue to advance, with four clinical data readouts anticipated in 2026; APG777 trial readout timelines accelerated, with Phase 1b in asthma and APEX 52-week Part A data in AD ...

Windy City Wire, a leading U.S. manufacturer of low-voltage wire and cable solutions, has announced a new educational webinar in partnership with iBwave Solutions Inc. The event is designed to help ...

PHILADELPHIA, Nov. 10, 2025 (GLOBE NEWSWIRE) -- via IBN – Datavault AI (Nasdaq: DVLT) (“Datavault”), a leader in data tokenization and ...